Tech Company Financing Transactions
PROCEPT BioRobotics Funding Round
PROCEPT BioRobotics secured a $118 million funding round on 2/22/2018. Investors included Viking Global Investors, CPMG and Perceptive Advisors.
Transaction Overview
Company Name
Announced On
2/22/2018
Transaction Type
Venture Equity
Amount
$118,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The financing will support the worldwide commercialization of the company's Aquablation therapy for the minimally invasive treatment of benign prostatic hyperplasia (BPH).
Company Information
Company Status
Publicly-held
Industry
Robotics
Mailing Address
900 Island Dr. 210
Redwood Shores, CA 94065
USA
Redwood Shores, CA 94065
USA
Phone
Website
Email Address
Overview
PROCEPT BioRobotics is a medical device company that develops a novel minimally invasive technology to surgically treat prostate disease. The first product developed is the AquaBeam, an intelligent image-guided robotic system delivering Aquablation, a personalized waterjet tissue resection modality.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Reza Zadno
Vice President
Matthew Salkeld
VP - General Counsel
Alaleh Nouri
VP - R & D
Surag Mantri
VP - Regulatory Affairs
Bijesh Chandran
VP - Regulatory Affairs
Barry Templin
Browse more venture capital transactions:
Prev: 2/22/2018: Prophesee venture capital transaction
Next: 2/22/2018: Vectra venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs